Cornerstone Capital, Inc. Amgen Inc Transaction History

Cornerstone Capital, Inc.

$1.06 Billion
Q3 2024

A detailed history of Cornerstone Capital, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cornerstone Capital, Inc. holds 106,538 shares of AMGN stock, worth $34 Million. This represents 3.23% of its overall portfolio holdings.

Number of Shares

106,538

Previous 103,278 3.16%

Holding current value

$34 Million

Previous $32.3 Million 6.38%

% of portfolio

3.23%

Previous 3.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$309.38 - $337.38 $1.01 Million - $1.1 Million	3,260 Added 3.16%	106,538 $34.3 Million
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $326,598 - $396,902	-1,243 Reduced 1.19%	103,278 $32.3 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $634,533 - $765,961	-2,360 Reduced 2.21%	104,521 $29.7 Million
Q4 2023 Feb 02, 2024	SELL	$255.7 - $288.46 $526,230 - $593,650	-2,058 Reduced 1.89%	106,881 $30.8 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $112,167 - $139,258	-513 Reduced 0.47%	108,939 $29.3 Million
Q2 2023 Aug 21, 2023	SELL	$214.27 - $253.37 $1.53 Million - $1.81 Million	-7,138 Reduced 6.12%	109,452 $24.3 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $706,722 - $861,376	3,130 Added 2.76%	116,590 $28.2 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $13,054 - $16,587	57 Added 0.05%	113,460 $29.8 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $396,171 - $446,809	1,765 Added 1.58%	113,403 $25.6 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $8,536 - $9,499	-37 Reduced 0.03%	111,638 $27.2 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.29 Million - $1.43 Million	5,897 Added 5.57%	111,675 $27 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $1.83 Million - $2.09 Million	9,185 Added 9.51%	105,778 $23.8 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $243,261 - $285,010	1,146 Added 1.2%	96,593 $20.5 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $582,081 - $645,776	2,492 Added 2.68%	95,447 $23.3 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $1.07 Million - $1.25 Million	4,823 Added 5.47%	92,955 $23.1 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $279,130 - $332,394	1,290 Added 1.49%	88,132 $20.3 Million
Q3 2020 Oct 27, 2020	BUY	$234.65 - $260.95 $481,032 - $534,947	2,050 Added 2.42%	86,842 $22.1 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $616,178 - $756,135	-3,115 Reduced 3.54%	84,792 $20 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $952,750 - $1.26 Million	-5,228 Reduced 5.61%	87,907 $17.8 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $1.22 Million - $1.57 Million	6,467 Added 7.46%	93,135 $22.5 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $518,847 - $621,687	2,980 Added 3.56%	86,668 $16.8 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $1.28 Million - $1.5 Million	7,696 Added 10.13%	83,688 $15.4 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $86,636 - $97,658	-479 Reduced 0.63%	75,992 $14.4 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $1.84 Million - $2.14 Million	10,300 Added 15.57%	76,471 $14.9 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $454,886 - $512,824	2,455 Added 3.85%	66,171 $13.7 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $236,953 - $266,149	1,427 Added 2.29%	63,716 $11.8 Million
Q1 2018 May 08, 2018	BUY	$169.43 - $198.0 $493,888 - $577,170	2,915 Added 4.91%	62,289 $10.6 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $1.36 Million - $1.52 Million	8,072 Added 15.73%	59,374 $10.3 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $8.58 Million - $9.8 Million	51,302	51,302 $9.57 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

417M

Call Options Held

7.18M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Capital, Inc. with notifications on news.

Account

Cornerstone Capital, Inc. Amgen Inc Transaction History